Leukemia drug shows promise for treating a childhood brain cancer

Share this post

Researchers describe a new use of leukemia drug, nilotinib, to treat a subtype of medulloblastoma, a deadly pediatric brain cancer.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply